Park Edge Advisors’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$213K Hold
2,479
0.04% 147
2026
Q1
$224K Hold
2,479
0.05% 130
2025
Q4
$223K Sell
2,479
-692
-22% -$65.6K 0.05% 139
2025
Q3
$312K Hold
3,171
0.07% 121
2025
Q2
$289K Hold
3,171
0.07% 123
2025
Q1
$359K Hold
3,171
0.1% 103
2024
Q4
$335K Hold
3,171
0.1% 107
2024
Q3
$342K Hold
3,171
0.1% 109
2024
Q2
$344K Hold
3,171
0.11% 103
2024
Q1
$419K Sell
3,171
-100
-3% -$12.5K 0.12% 86
2023
Q4
$398K Hold
3,271
0.14% 80
2023
Q3
$367K Hold
3,271
0.13% 72
2023
Q2
$476K Hold
3,271
0.16% 63
2023
Q1
$423K Sell
3,271
-142
-4% -$17.8K 0.16% 60
2022
Q4
$435K Buy
+3,413
New +$396K 0.19% 59

Other funds holding ZBH

Park Edge Advisors's ZBH Position: Q2 2026 in Review

Park Edge Advisors held its Zimmer Biomet (ZBH) position steady in Q2 2026 at 2,479 shares worth $213K. The position accounts for 0.04% of the portfolio, ranked #147.

Park Edge Advisors first reported a position in ZBH in Q4 2022 and has held it in 15 quarters since. The position peaked at $476K in Q2 2023. 113 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Park Edge Advisors held 2,479 shares of Zimmer Biomet worth $213K as of Q2 2026.
  • Park Edge Advisors left its Zimmer Biomet share count unchanged in Q2 2026.
  • Zimmer Biomet made up 0.04% of Park Edge Advisors's portfolio in Q2 2026, its #147 holding.
  • Park Edge Advisors first reported a position in Zimmer Biomet in Q4 2022 and has held it in 15 quarters since.
  • Park Edge Advisors's Zimmer Biomet position peaked at $476K in Q2 2023.
  • 113 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Park Edge Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.